TM4SF5 and hepatocellular carcinoma: Other changes observed in TM4SF5 expressing HCC cells treated with anti-TM4SF5 antibody were nuclear translocation of the CDK inhibitor p27kip1 and increased activity of a small GTP protein RhoA [42].